Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pure Global Cannabis Inc PRCNF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Pure Global Cannabis Inc is a growth-oriented life science cannabis company led by experienced pharma-industry, horticultural and supply chain experts.


GREY:PRCNF - Post by User

Pure Global Cannabis Inc > Time to buy!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(38)
•••
Comment by Toelderon Jan 13, 2020 10:23am
119 Views
Post# 30546076

RE:RE:RE:RE:RE:Time to buy!

RE:RE:RE:RE:RE:Time to buy!
AREKAY1 wrote: Jonass-this assessment seems accurate. Do you know what the gating item is on the financing? This appears to have been in the works for a couple of months now. 


Yeah it takes forever.

I hope they come with a substantial NR soon, because the SP is falling and falling. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities